Ignyta Strikes Clinical Trial Deal With UC San Francisco

Email not displaying correctly?
View it in your browser.
G2 LogoLab and Pathology Insider Logo
 
July 14, 2015

Theranos Receives First FDA Clearance, Inks Deal with Capital BlueCross

By Stephanie Murg, Managing Director, G2 Intelligence

July is proving to be a month of milestones for Theranos (Palo Alto, Calif.). The company recently received its first FDA clearance—for its herpes simplex virus-1 (HSV-1) IgG assay—and announced a partnership with Pennsylvania health insurer Capital BlueCross (Harrisburg, Penn.) that will pave the way for the first Theranos patient service centers on the East Coast. Meanwhile…

Read more...


White House Releases Precision Medicine Privacy Principles

By Kelly A. Briganti, Editorial Director, G2 Intelligence

While promoting a personalized approach to medicine which involves more sharing of data, the Obama administration isn't neglecting the need to protect privacy when it comes to health information. The White House released July 8 Proposed Privacy and Trust Principles as part of the Precision Medicine Initiative. These principles provide guidance on access to, sharing and use of data as well as…

Read more...


Leverage Your Laboratory Data into Value with the Orchard School of Medical Analytics

In the new value-focused healthcare paradigm, the need for laboratory data is more apparent than ever. Not only can laboratory data be used to aid in diagnosis and treatment plans, it can be combined with other data and used to greatly reduce overall organization-wide costs in areas far beyond the lab. The value of the clinical data that the laboratory produces is invaluable, yet its potential to drive change that leads to positive patient outcomes and cost savings is worth much more.

The Orchard School of Medical Analytics, an offering from Orchard Analytics, which is a new business unit of Orchard Software, will educate pathologists and healthcare leaders in the use of advanced analytics to improve patient care and reduce costs. The four day course will provide pathologists and laboratory leaders with an opportunity to prepare for the future by studying proven strategies in which laboratory data compiled with billing, pharmacy, and other clinical data has been successfully used to save money and improve patient care.

The course will be led by Dr. Brad Brimhall, who is an expert in medical analytics and data warehousing. The course will include instruction on healthcare organizational structures, cost-accounting, accounting for quality, medical data and databases, and a review of analytics projects and presentation skills. For more information on the Orchard School of Medical Analytics, contact orchard at (800) 856-1948.


Genomics Could Eclipse Other Largest Data Generators by 2025

By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies

Data generated from genomics may exceed the largest generators of big data in other industries by 2025, according to a study published July 7 in PLOS Biology. Genomics' data requirements were compared to the current biggest generators of data—astronomy, YouTube, and Twitter—across the…

Read more...


Ignyta Strikes Clinical Trial Deal With UC San Francisco

By Ron Shinkman, Editor, Laboratory Industry Report

Ignyta, the San Diego-based pharmaceutical and personal diagnostics firm, has entered into a collaboration with the University of California at San Francisco (UCSF) for a clinical trial regarding the treatment of patients with metastatic melanoma…

Read more...


Follow on Twitter  Forward to Friend 

For questions concerning delivery of this email, please contact customer service at: (888) 729-2315 | customerservice@plainlanguagemedia.com

Copyright © 2015, All rights reserved.
Plain Language Media LLLP
PO Box 509
New London, CT
06320